Page 1 of Clinical Trials for Drug azacitidine, 210 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Azacytidine and Valproic Acid in Patients With Advanced Cancers
Last Updated: October 26, 2009
Condition(s): Advanced Cancers
2
Recruiting
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
Last Updated: August 5, 2008
Condition(s): Acute Myeloid Leukemia; Elderly
3
Recruiting
Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes
Last Updated: November 21, 2011
Condition(s): MDS
4
Recruiting
Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors
Last Updated: April 20, 2012
Condition(s): Relapsed or Refractory Solid Tumors
5
Completed
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
Last Updated: June 3, 2011
Condition(s): MDS; Myelodysplastic Syndromes; Thrombocytopenia
6
Recruiting
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age
Last Updated: May 1, 2012
Condition(s): Acute Myeloid Leukemia; Acute Myelogenous Leukemia
7
Recruiting
5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Last Updated: May 14, 2012
Condition(s): Advanced Cancer; Solid Tumor; Lymphoma
8
Recruiting
Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)
Last Updated: November 17, 2009
Condition(s): Myelodysplastic Syndromes
9
Recruiting
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Last Updated: March 29, 2012
Condition(s): Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid Leukemia
10
Recruiting
A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)
Last Updated: April 6, 2012
Condition(s): Acute Myeloid Leukemia
11
Recruiting
Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)
Last Updated: September 27, 2011
Condition(s): Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS)
12
Recruiting
Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
Last Updated: June 12, 2011
Condition(s): Follicular Lymphoma; Marginal Zone Lymphoma
13
Recruiting
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Last Updated: April 9, 2010
Condition(s): Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
14
Recruiting
Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Last Updated: May 24, 2012
Condition(s): Leukemia; Myelodysplastic Syndromes
15
Active, not recruiting
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer
Last Updated: October 5, 2011
Condition(s): Non-small Cell Lung Cancer; Squamous Cell Carcinoma of the Head and Neck
16
Suspended
Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Last Updated: February 16, 2012
Condition(s): Acute Myeloid Leukemia
17
Recruiting
Azacitidine and Lenalidomide for Acute Myeloid Leukemia
Last Updated: October 6, 2011
Condition(s): Leukemia, Myeloid, Acute
18
Recruiting
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
Last Updated: October 6, 2011
Condition(s): Myelodysplastic Syndromes
19
Recruiting
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Last Updated: March 17, 2011
Condition(s): Leukemia; Myelodysplastic Syndromes
20
Recruiting
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia
Last Updated: May 24, 2012
Condition(s): Leukemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+azacitidine

Page 1 of Clinical Trials for Drug azacitidine, 210 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About